Certain agents may mitigate pain associated with neuropathy, fibromyalgia, headache, and IBS.
Age-related variations in presentation, treatment response may warrant a different approach.
Symptoms can overlap, but accurate diagnosis is critical because treatments are distinct.
Inducing systemic inflammation has adverse effects on cognition and behavior, whereas suppressing inflammation can improve sensorium and mood.
Anticholinergics, antidepressants, antipsychotics, and gabapentinoids may also be subject to misuse or abuse.
Evidence suggests combining lifestyle modifications may yield better cognitive outcomes.
Here we summarize 3 studies to describe which patients might be optimal candidates for XR-NTX, its success in comparison with BUP-NX, and...
Botulinum toxin has shown promising antidepressant effects, and might be helpful for several other indications.
Few pharmacologic options, but evidence supports combining psychosocial interventions.
Out Of The Pipeline
RBP-7000 (Perseris) is the second long-acting injectable form of risperidone
approved in the United States.
Consider the urine drug screen as a tool for improving patients’ treatment adherence and clinical outcomes.